|
1
|
Di Palo KE and Barone NJ: Hypertension and
heart failure: Prevention, targets, and treatment. Heart Fail Clin.
16:99–106. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang W, Wang Q, Feng Y, Chen X, Yang L,
Xu M, Wang X, Li W, Niu X and Gao D: MicroRNA-26a protects the
heart against hypertension-induced myocardial fibrosis. J Am Heart
Assoc. 9(e017970)2020.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen Y, Lu W, Yang K, Duan X, Li M, Chen
X, Zhang J, Kuang M, Liu S, Wu X, et al: Tetramethylpyrazine: A
promising drug for the treatment of pulmonary hypertension. Br J
Pharmacol. 177:2743–2764. 2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Zhao H, Wang Y, Zhang X, Guo Y and Wang X:
miR-181b-5p inhibits endothelial-mesenchymal transition in
monocrotaline-induced pulmonary arterial hypertension by targeting
endocan and TGFBR1. Toxicol Appl Pharmacol.
386(114827)2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dong ZC, Wu MM, Zhang YL, Wang QS, Liang
C, Yan X, Zou LX, Chen C, Han X, Zhang B and Zhang ZR: The vascular
endothelial growth factor trap aflibercept induces vascular
dysfunction and hypertension via attenuation of eNOS/NO signaling
in mice. Acta Pharmacol Sin. 42:1437–1448. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Mokotedi L, Millen AME, Mogane C, Gomes M,
Woodiwiss AJ, Norton GR and Michel FS: Associations of inflammatory
markers and vascular cell adhesion molecule-1 with endothelial
dysfunction in collagen-induced arthritis. Eur J Pharmacol.
865(172786)2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Canpolat U, Kocyigit D and Yildirim A:
Role of endothelial dysfunction and endocan in atherosclerosis:
Point of origin or end point? Angiology. 71(477)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Bhagwani AR, Hultman S, Farkas D, Moncayo
R, Dandamudi K, Zadu AK, Cool CD and Farkas L: Endothelial cells
are a source of nestin expression in pulmonary arterial
hypertension. PLoS One. 14(e0213890)2019.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Luo S, Xia W, Chen C, Robinson EA and Tao
J: Endothelial progenitor cells and hypertension: Current concepts
and future implications. Clin Sci (Lond). 130:2029–2042.
2016.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Masi S, Uliana M and Virdis A: Angiotensin
II and vascular damage in hypertension: Role of oxidative stress
and sympathetic activation. Vascul Pharmacol. 115:13–17.
2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Ballard KD, Timsina R and Timmerman KL:
Influence of time of day and intermittent aerobic exercise on
vascular endothelial function and plasma endothelin-1 in healthy
adults. Chronobiol Int. 1–8. 2021.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Zhang X, Hu C, Yuan YP, Song P, Kong CY,
Wu HM, Xu SC, Ma ZG and Tang QZ: Endothelial ERG alleviates cardiac
fibrosis via blocking endothelin-1-dependent paracrine mechanism.
Cell Biol Toxicol. 37:873–890. 2021.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Hu C and Dong ZL: MicroRNA-212 promotes
the recovery function and vascular regeneration of endothelial
progenitor cells in mice with ischemic stroke through inactivation
of the notch signaling pathway via downregulating MMP9 expression.
J Cell Physiol. 234:7090–7103. 2019.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Gentilini A, Lori G, Caligiuri A, Raggi C,
Maira GD, Pastore M, Piombanti B, Lottini T, Arcangeli A, Madiai S,
et al: Extracellular signal-regulated kinase 5 regulates the
malignant phenotype of cholangiocarcinoma cells. Hepatology.
74:2007–2020. 2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Curran MP: Amlodipine/Atorvastatin: A
review of its use in the treatment of hypertension and
dyslipidaemia and the prevention of cardiovascular disease. Drugs.
70:191–213. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Fang T, Guo B, Xue L and Wang L:
Atorvastatin prevents myocardial fibrosis in spontaneous
hypertension via interleukin-6 (IL-6)/signal transducer and
activator of transcription 3 (STAT3)/endothelin-1 (ET-1) pathway.
Med Sci Monit. 25:318–323. 2019.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Yuan H, Wang D, Zhang Y and Geng J:
Atorvastatin attenuates vascular remodelling in spontaneously
hypertensive rats via the protein kinase D/extracellular
signal-regulated kinase 5 pathway. Clin Exp Pharmacol Physiol.
47:1429–1438. 2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Nagayama D, Saiki A, Watanabe Y, Yamaguchi
T, Ohira M, Sato N, Kanayama M, Moroi M, Miyashita Y, Shirai K and
Tatsuno I: Prevention of cardiovascular events with pitavastatin is
associated with increased serum lipoprotein lipase mass level:
Subgroup analysis of the TOHO-LIP. J Atheroscler Thromb: Feb 27,
2021. doi: 10.5551/jat.62141.
|
|
19
|
Bhatti H and Tadi P: Pitavastatin. In:
StatPearls, StatPearls Publishing, Treasure Island, FL, 2021.
|
|
20
|
Cao Y, Gong Y, Liu L, Zhou Y, Fang X,
Zhang C, Li Y and Li J: The use of human umbilical vein endothelial
cells (HUVECs) as an in vitro model to assess the toxicity of
nanoparticles to endothelium: A review. J Appl Toxicol.
37:1359–1369. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Rajendran S, Shen X, Glawe J, Kolluru GK
and Kevil CG: Nitric oxide and hydrogen sulfide regulation of
ischemic vascular growth and remodeling. Compr Physiol.
9:1213–1247. 2019.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Bonnefont-Rousselot D: Resveratrol and
cardiovascular diseases. Nutrients. 8(250)2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Jankowich M and Choudhary G: Endothelin-1
levels and cardiovascular events. Trends Cardiovasc Med. 30:1–8.
2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Yamada T, Egashira N, Imuta M, Yano T,
Yamauchi Y, Watanabe H and Oishi R: Role of oxidative stress in
vinorelbine-induced vascular endothelial cell injury. Free Radic
Biol Med. 48:120–127. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Zhang M, Wang X, Yao J and Qiu Z: Long
non-coding RNA NEAT1 inhibits oxidative stress-induced vascular
endothelial cell injury by activating the miR-181d-5p/CDKN3 axis.
Artif Cells Nanomed Biotechnol. 47:3129–3137. 2019.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Nakamura-Utsunomiya A, Tsumura M, Okada S,
Kawaguchi H and Kobayashi M: Downregulation of endothelial nitric
oxide synthase (eNOS) and endothelin-1 (ET-1) in a co-culture
system with human stimulated X-linked CGD neutrophils. PLoS One.
15(e0230665)2020.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Walshe TE, Ferguson G, Connell P, O'Brien
C and Cahill PA: Pulsatile flow increases the expression of eNOS,
ET-1, and prostacyclin in a novel in vitro coculture model of the
retinal vasculature. Invest Ophthalmol Vis Sci. 46:375–382.
2005.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Castilla-Guerra L, Fernandez-Moreno MD and
Colmenero-Camacho MA: Statins in Stroke Prevention: Present and
future. Curr Pharm Des. 22:4638–4644. 2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Koushki K, Shahbaz SK, Mashayekhi K,
Sadeghi M, Zayeri ZD, Taba MY, Banach M, Al-Rasadi K, Johnston TP
and Sahebkar A: Anti-inflammatory action of statins in
cardiovascular disease: The role of inflammasome and toll-like
receptor pathways. Clin Rev Allergy Immunol. 60:175–199.
2021.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Mo S, Qian Y, Zhang W, Qian L, Wang Y,
Cailin G and Ding H: Mitogen-activated protein kinase action in
plant response to high-temperature stress: A mini review.
Protoplasma. 258:477–482. 2021.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kim M, Jeong S, Lim CW and Lee SC:
Mitogen-activated protein kinase CaDIMK1 functions as a positive
regulator of drought stress response and abscisic acid signaling in
capsicum annuum. Front Plant Sci. 12(646707)2021.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lochhead PA, Clark J, Wang LZ, Gilmour L,
Squires M, Gilley R, Foxton C, Newell DR, Wedge SR and Cook SJ:
Tumor cells with KRAS or BRAF mutations or ERK5/MAPK7 amplification
are not addicted to ERK5 activity for cell proliferation. Cell
Cycle. 15:506–518. 2016.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Gavine PR, Wang M, Yu D, Hu E, Huang C,
Xia J, Su X, Fan J, Zhang T, Ye Q, et al: Identification and
validation of dysregulated MAPK7 (ERK5) as a novel oncogenic target
in squamous cell lung and esophageal carcinoma. BMC Cancer.
15(454)2015.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Nithianandarajah-Jones GN, Wilm B,
Goldring CE, Müller J and Cross MJ: ERK5: structure, regulation and
function. Cell Signal. 24:2187–2196. 2012.PubMed/NCBI View Article : Google Scholar
|
